Article
CRISPR screen for rAAV production implicates genes associated with infection
2024-09-18
Abstract excerpt
<h4>ABSTRACT</h4> Recombinant adeno-associated virus (rAAV) vectors are an effective and well-established tool in the growing gene therapy field, with five FDA-approved AAV-mediated gene therapies already on the market and numerous more in clinical trials. However, manufacturing rAAV vectors is an expensive, timely, and labor-intensive process that limits the commercial use of AAV-mediated gene therapies. To addr...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e37d3149-4cfe-57d2-bac9-cd9900507694
- DOI
- 10.1101/2024.09.17.613356
